RGEN Q1 2025 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q1 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$169M+10.4% YoY

Gross Profit

$91M53.6% margin

Operating Income

$7M3.9% margin

Net Income

$6M3.4% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+1.0%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$867M

Stockholders' Equity

$2.0B

Cash & Equivalents

$697M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$169M	$153M	+10.4%
Gross Profit	$91M	$77M	+18.2%
Operating Income	$7M	$4M	+75.4%
Net Income	$6M	$3M	+76.9%

Revenue Segments

Product

$169M100%

Royalty

$35,0000%